PTC (NASDAQ: PTC) will release its fiscal 2026 first quarter and on Wednesday, February 4 th after the stock market closes.

PTC (PTC) is drawing investor attention after a recent stretch of weaker share performance, with the stock showing declines ...

Conference draws participants from more than 60 countries; demand for leadership programs reaches capacity From sold ...

Founded in 1985, the Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid ...

PTC Therapeutics is keeping its regulatory teams busy. In its third-quarter results, the biotech reported pushback against its plans to seek approval for two molecules based on existing data—and saw ...

PTC (NASDAQ: PTC) today announced new artificial intelligence (AI) capabilities for its FlexPLM® retail product lifecycle ...

Shares of PTC Inc. PTC shed 1.18% to $171.52 Friday, on what proved to be an all-around great trading session for the stock ...

PTC Therapeutics (PTCT) beats 2025 revenue guidance, details Evrysdi royalties and Sephience growth, and sets 2026 outlook.

PTC's solutions are helping enable a digital revolution in manufacturing, and its long-term growth looks assured. Management's guidance means PTC's growth will be heavily weighted to the second half ...

Amid a cost-cutting drive and a looming commercial threat in Europe, PTC Therapeutics is raising cash in a new royalty deal. In an agreement with Royalty Pharma worth up to $1.5 billion, PTC agreed to ...